HHS ousts vaccine injury panel members as reshaping takes holdnews2026-01-13T18:32:24+00:00January 13th, 2026|Endpoints News|
Trump administration appears to have ended its US trade probe into pharmanews2026-01-13T18:02:35+00:00January 13th, 2026|Endpoints News|
VantAI gets $80M and new name; Dynavax discloses it had pre-Sanofi suitornews2026-01-13T16:22:37+00:00January 13th, 2026|Endpoints News|
AbbVie reaches MFN deal with the White House, pledges billions to US manufacturingnews2026-01-13T14:53:42+00:00January 13th, 2026|Endpoints News|
Marea takes drug for acromegaly to Phase 2news2026-01-13T13:00:12+00:00January 13th, 2026|Endpoints News|
Novartis licenses radiopharma asset from Chinese biotech for $50M upfrontnews2026-01-13T12:07:22+00:00January 13th, 2026|Endpoints News|
#JPM26: Day 2 at the JP Morgan Healthcare Conferencenews2026-01-13T12:00:15+00:00January 13th, 2026|Endpoints News|
Sentynl gets the first US approval for rare copper absorption diseasenews2026-01-13T10:49:44+00:00January 13th, 2026|Endpoints News|
Treg biotech Sonoma sheds staff after getting new CEOnews2026-01-13T09:13:48+00:00January 13th, 2026|Endpoints News|
